Načítá se...
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
Multiple myeloma is an incurable malignancy of plasma B-cells. Traditional chemotherapeutic regimes often induce initial tumor regression; however, virtually all patients eventually succumb to relapse caused by either reintroduction of disease during autologous transplant or expansion of chemotherap...
Uloženo v:
| Vydáno v: | Mol Ther Oncolytics |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5142464/ https://ncbi.nlm.nih.gov/pubmed/27933316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.32 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|